References
- Seah DSE, Herschtal A, Tran H, Thakerar A, Fullerton S. Subcutaneous lidocaine infusion for pain in patients with cancer. J Palliat Med. 2017;20(6):667–71. doi:10.1089/jpm.2016.0298.
- Ferguson L, Al Ruheili J, Clark H, Barham D. Subcutaneous lidocaine infusion for complex cancer pain: a retrospective review. J Pain Palliat Care Pharmacother. 2021;35(3):137–42. doi:10.1080/15360288.2021.1920544.
- Hawley P, Fyles G, Jefferys SG. Subcutaneous lidocaine for cancer-related pain. J Palliat Med. 2020;23(10):1357–64. doi:10.1089/jpm.2019.0621.
- Eipe N, Gupta S, Penning J. Intravenous lidocaine for acute pain: an evidence-based clinical update. BJA Educ. 2016;16(9):292–8. doi:10.1093/bjaed/mkw008.
- Reid PD, Cifu AS, Bass AR. Management of immunotherapy-related toxicities in patients treated with immune checkpoint inhibitor therapy. JAMA. 2021;325(5):482–3. doi:10.1001/jama.2020.17308.
- Braaten TJ, Brahmer JR, Forde PM, Le D, Lipson EJ, Naidoo J, Schollenberger M, Zheng L, Bingham CO, Shah AA, et al. Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation. Ann Rheum Dis. 2020;79(3):332–8. doi:10.1136/annrheumdis-2019-216109.
- Durrechou Q, Domblides C, Sionneau B, Lefort F, Quivy A, Ravaud A, Gross-Goupil M, Daste A. Management of immune checkpoint inhibitor toxicities. Cancer Manag Res. 2020;12:9139–58. doi:10.2147/CMAR.S218756.
- Reid P, Liew DF, Akruwala R, Bass AR, Chan KK. Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study. J Immunother Cancer. 2021;9(9):1–7. doi:10.1136/jitc-2021-003260.
- Kandil E, Melikman E, Adinoff B. Lidocaine infusion: a promising therapeutic approach for chronic pain. J Anesth Clin Res. 2017;8(1):1–29. doi:10.4172/2155-6148.1000697.
- Peixoto RDA, Hawley P. Intravenous lidocaine for cancer pain without electrocardiographic monitoring: a retrospective review. J Palliat Med. 2015;18(4):373–7. doi:10.1089/jpm.2014.0279.
- Reeves DJ, Foster AE. Continuous intravenous lidocaine infusion for the management of pain uncontrolled by opioid medications. J Pain Palliat Care Pharmacother. 2017;31(3-4):198–203. doi:10.1080/15360288.2017.1313356.
- Cappelli LC, Grieb SM, Shah AA, Bingham CO, Orbai A-M. Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps. BMC Rheumatol. 2020;4(1):32. doi:10.1186/s41927-020-00133-8.